It’s a very different world now in cancer,” said longtime patient advocate Ginny Mason. “Now you need to understand the ...

Dr. Rainer Storb began studying bone marrow transplantation when the field was in its infancy. As he retires 60 years later, ...

Researchers at Fred Hutch Cancer Center invented a new screening method called ReLiC that uses CRISPR-Cas9 to test all the ...

A study published in Nature shows that certain autoantibodies may influence how cancer patients respond to immunotherapy. Autoantibodies are proteins produced by the immune system and have typically ...

Celebrate the Annual Celebrity Steak-Out! Join us for an evening of food, fun and philanthropy at Celebrity Steak-Out presented by Brotherton Cadillac Buick GMC. A silent auction and cocktail hour ...

Pain Clinic Services Cancer pain care needs to be carefully coordinated. It requires careful follow-up of issues and medications that can complicate a patient’s overall care. Cancer pain changes ...

At first glance, art and science might seem like opposite worlds — one driven by imagination and emotion, the other by data ...

There's a growing interest in the use of bone-modifying agents, or BMAs, known as bisphosphonates in the cancer patient population. But these agents can cause short- and long-term side effects. What’s ...

On September 10, experts across disciplines, from infectious disease clinicians to regulators to representatives from the pharmaceutical industry, convened at the inaugural ImmunOptimize workshop in ...

It takes a persistent scientist to stop a persistent virus. A decade ago, Fred Hutchinson Cancer Research Center virologist Dr. Keith Jerome began exploring the idea that lifelong infections with ...

A small observational study out of the U.K. of breast cancer patients found that certain types of chemotherapy can weaken part of the immune system for up to nine months after treatment.